CoChat

Loss of P2X7 Receptor Plasma Membrane Expression and Function in Pathogenic B220+ Double-Negative T Lymphocytes of Autoimmune MRL/lpr Mice

Open access

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Lupus is a chronic inflammatory autoimmune disease influenced by multiple genetic loci including Fas Ligand (FasL) and P2X7 receptor (P2X7R). The Fas/Fas Ligand apoptotic pathway is critical for immune homeostasis and peripheral tolerance. Normal effector T lymphocytes up-regulate the transmembrane tyrosine phosphatase B220 before undergoing apoptosis. Fas-deficient MRL/lpr mice (lpr mutation) exhibit lupus and lymphoproliferative syndromes due to the massive accumulation of B220(+) CD4(-)CD8(-) (DN) T lymphocytes. The precise ontogeny of B220(+) DN T cells is unknown. B220(+) DN T lymphocytes could be derived from effector CD4(+) and CD8(+) T lymphocytes, which have not undergone activation-induced cell death due to inactivation of Fas, or from a special cell lineage. P2X7R is an extracellular ATP-gated cell membrane receptor involved in the release of proinflammatory cytokines and TNFR1/Fas-independent cell death. P2X7R also regulate early signaling events involved in T-cell activation. We show herein that MRL/lpr mice carry a P2X7R allele, which confers a high sensitivity to ATP. However, during aging, the MRL/lpr T-cell population exhibits a drastically reduced sensitivity to ATP- or NAD-mediated stimulation of P2X7R, which parallels the increase in B220(+) DN T-cell numbers in lymphoid organs. Importantly, we found that this B220(+) DN T-cell subpopulation has a defect in P2X7R-mediated responses. The few B220(+) T cells observed in normal MRL(+/+) and C57BL/6 mice are also resistant to ATP or NAD treatment. Unexpectedly, while P2X7R mRNA and proteins are present inside of B220(+) T cells, P2X7R are undetectable on the plasma membrane of these T cells. Our results prompt the conclusion that cell surface expression of B220 strongly correlates with the negative regulation of the P2X7R pathway in T cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0052161

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 P2X7R activity in T lymphocytes from normal MRL+/+ and autoimmune MRL/lpr mice. Spleen cells from 3 to 4-mo-old MRL+/+ (□) and MRL/lpr (▪) mice (n = 5 mice/group) were incubated with or without 500 µM ATP for 45 min (A–C) or 4 h (D) at 37°C. Cells were then double-stained with anti-CD90 mAb and either anti-CD62L mAb, YO-PRO-1, Annexin V or 7-AAD to assess in T cells by flow cytometry: (A) CD62L shedding; (B) pore formation; (C) cell surface PS exposure; (D) cell death. Numbers reported in the dot plots indicate the percentages of CD62L+CD90+ or YO-PRO-1+CD90+ cells in the gated CD90+ T-cell population. Histograms correspond to the mean percentages ± SE (n = 5 mice/group) of double-stained cells in the gated CD90+ T-cell population. Asterisks denote statistically significant differences (***p≤0.001) between ATP-stimulated and unstimulated groups.
Figure 1 P2X7R activity in T lymphocytes from normal MRL+/+ and autoimmune MRL/lpr mice. Spleen cells from 3 to 4-mo-old MRL+/+ (□) and MRL/lpr (▪) mice (n = 5 mice/group) were incubated with or without 500 µM ATP for 45 min (A–C) or 4 h (D) at 37°C. Cells were then double-stained with anti-CD90 mAb and either anti-CD62L mAb, YO-PRO-1, Annexin V or 7-AAD to assess in T cells by flow cytometry: (A) CD62L shedding; (B) pore formation; (C) cell surface PS exposure; (D) cell death. Numbers reported in the dot plots indicate the percentages of CD62L+CD90+ or YO-PRO-1+CD90+ cells in the gated CD90+ T-cell population. Histograms correspond to the mean percentages ± SE (n = 5 mice/group) of double-stained cells in the gated CD90+ T-cell population. Asterisks denote statistically significant differences (***p≤0.001) between ATP-stimulated and unstimulated groups.CC BY · PubMed Central
Figure 2 P2X7R antagonist KN-62 inhibits ATP-induced CD62L shedding and pore formation in MRL+/+ T lymphocytes. Spleen cells from 3 to 4-mo-old MRL+/+ mice (n = 4 mice/group) were preincubated for 15 min at 37°C with or without 0.5, 1 and 5 µM KN-62 and then stimulated with 500 µM ATP for 30 min. Cells were then double-stained with anti-CD90 mAb and either anti-CD62L or YO-PRO-1 to assess by flow cytometry: (A) CD62L shedding or (B) pore formation in the gated CD90+ T-cell population stimulated (▪) or not (□) with ATP. Asterisks denote statistically significant differences between ATP-stimulated and unstimulated groups: *p≤0.05; **p≤0.01; ***p≤0.001.
Figure 2 P2X7R antagonist KN-62 inhibits ATP-induced CD62L shedding and pore formation in MRL+/+ T lymphocytes. Spleen cells from 3 to 4-mo-old MRL+/+ mice (n = 4 mice/group) were preincubated for 15 min at 37°C with or without 0.5, 1 and 5 µM KN-62 and then stimulated with 500 µM ATP for 30 min. Cells were then double-stained with anti-CD90 mAb and either anti-CD62L or YO-PRO-1 to assess by flow cytometry: (A) CD62L shedding or (B) pore formation in the gated CD90+ T-cell population stimulated (▪) or not (□) with ATP. Asterisks denote statistically significant differences between ATP-stimulated and unstimulated groups: *p≤0.05; **p≤0.01; ***p≤0.001.CC BY · PubMed Central
Figure 3 Dose–response experiments for ATP-induced CD62L shedding on T lymphocytes. Spleen cells from 3 to 4-mo-old MRL+/+ (solid line), MRL/lpr (dashed line) and P2X7-deficient B6P2X7R−/− (dotted line) mice (n = 3 mice/group) were treated for 45 min at 37°C with doses of ATP ranging from 100 to 5000 µM. Spleen cells were then triple-stained with anti-CD90, anti-CD19 and anti-CD62L mAb to assess by flow cytometry: (A) the percentage of CD62L-expressing CD19–CD90+ T cells and (B) MFI of CD62L on CD19–CD90+ T cells. Results are expressed as the mean percentage of initial expression ± SE.
Figure 3 Dose–response experiments for ATP-induced CD62L shedding on T lymphocytes. Spleen cells from 3 to 4-mo-old MRL+/+ (solid line), MRL/lpr (dashed line) and P2X7-deficient B6P2X7R−/− (dotted line) mice (n = 3 mice/group) were treated for 45 min at 37°C with doses of ATP ranging from 100 to 5000 µM. Spleen cells were then triple-stained with anti-CD90, anti-CD19 and anti-CD62L mAb to assess by flow cytometry: (A) the percentage of CD62L-expressing CD19–CD90+ T cells and (B) MFI of CD62L on CD19–CD90+ T cells. Results are expressed as the mean percentage of initial expression ± SE.CC BY · PubMed Central
Figure 4 Metalloprotease inhibitors GM6001 and Ro 31–9790 inhibit PMA/Iono- and ATP-induced shedding of CD62L on MRL+/+ T lymphocytes. Spleen cells from MRL+/+ and MRL/lpr mice (n = 5 mice/group) were preincubated with or without 10, 25, 50, 100 µM GM6001 or 3, 30, 100 µM Ro 31–9790 for 15 min at 37°C, and then either left unstimulated (□) or stimulated with 500 µM ATP (▴) or 5 ng/ml PMA plus 0.5 µg/ml Ionomycin (○) for 45 min at 37°C. Cells were subsequently stained with anti-CD90 and anti-CD62L mAb. Cell surface expression of CD62L was assessed in the gated CD90+ T cells by flow cytometry.
Figure 4 Metalloprotease inhibitors GM6001 and Ro 31–9790 inhibit PMA/Iono- and ATP-induced shedding of CD62L on MRL+/+ T lymphocytes. Spleen cells from MRL+/+ and MRL/lpr mice (n = 5 mice/group) were preincubated with or without 10, 25, 50, 100 µM GM6001 or 3, 30, 100 µM Ro 31–9790 for 15 min at 37°C, and then either left unstimulated (□) or stimulated with 500 µM ATP (▴) or 5 ng/ml PMA plus 0.5 µg/ml Ionomycin (○) for 45 min at 37°C. Cells were subsequently stained with anti-CD90 and anti-CD62L mAb. Cell surface expression of CD62L was assessed in the gated CD90+ T cells by flow cytometry.CC BY · PubMed Central
Figure 5 P2X7R activity in T lymphocytes from MRL/lpr mice at early and late stages of the disease, and in B220+ and B220– T lymphocytes from MRL+/+ and MRL/lpr mice. (A and B) Spleen cells from 4-mo-old MRL+/+ and 2- and 4-mo-old MRL/lpr mice (n = 3 mice/group) were either left unstimulated (□) or stimulated with 500 µM ATP (▪) or 50 µM NAD (▪) for 45 min at 37°C. Cells were then double-stained with anti-CD90 mAb and either Annexin V or YO-PRO-1 to assess PS exposure and pore formation, respectively, in the gated CD90+ T-cell population by flow cytometry. (C–E) Spleen cells from 3 to 5-mo-old MRL+/+ and MRL/lpr (n = 5 mice/group) were either left unstimulated (□) or stimulated with 500 µM ATP (▪) or 50 µM NAD (▪) for 45 min at 37°C. Cells were then triple-stained with anti-CD90, anti-B220 and either anti-CD62L mAb, YO-PRO-1 or 7-AAD to assess CD62L shedding (C), pore formation (D) or cell death (E) in B220–CD90+ and B220+CD90+ T-cell subsets. Asterisks denote statistically significant differences between ATP- or NAD-stimulated and unstimulated groups: **p≤0.01; ***p≤0.001.
Figure 5 P2X7R activity in T lymphocytes from MRL/lpr mice at early and late stages of the disease, and in B220+ and B220– T lymphocytes from MRL+/+ and MRL/lpr mice. (A and B) Spleen cells from 4-mo-old MRL+/+ and 2- and 4-mo-old MRL/lpr mice (n = 3 mice/group) were either left unstimulated (□) or stimulated with 500 µM ATP (▪) or 50 µM NAD (▪) for 45 min at 37°C. Cells were then double-stained with anti-CD90 mAb and either Annexin V or YO-PRO-1 to assess PS exposure and pore formation, respectively, in the gated CD90+ T-cell population by flow cytometry. (C–E) Spleen cells from 3 to 5-mo-old MRL+/+ and MRL/lpr (n = 5 mice/group) were either left unstimulated (□) or stimulated with 500 µM ATP (▪) or 50 µM NAD (▪) for 45 min at 37°C. Cells were then triple-stained with anti-CD90, anti-B220 and either anti-CD62L mAb, YO-PRO-1 or 7-AAD to assess CD62L shedding (C), pore formation (D) or cell death (E) in B220–CD90+ and B220+CD90+ T-cell subsets. Asterisks denote statistically significant differences between ATP- or NAD-stimulated and unstimulated groups: **p≤0.01; ***p≤0.001.CC BY · PubMed Central
Figure 6 Real-time kinetic analysis of calcium influx in B220– and B220+ T lymphocytes stimulated with ATP. Spleen cells from 4-mo-old MRL+/+ (red) MRL/lpr (blue) and B6P2X7−/− (black) mice (n = 3 mice/group) were loaded with calcium-reactive fluorescence probe, Oregon Green 488 BAPTA-1. After loading, cells were stained with anti-CD90, anti-CD19 and anti-B220 mAbs. Baseline MFI of the calcium probe was recorded in the gated B220–CD90+ (○) and B220+CD90+ (▵) T cells during 50 s by flow cytometry, and was followed by the addition of 500 µM ATP (at time t0, arrow). Changes over time in MFI values of the calcium probe were monitored in the T-cell subsets by flow cytometry. MFI values were normalized by subtracting the baseline MFI.
Figure 6 Real-time kinetic analysis of calcium influx in B220– and B220+ T lymphocytes stimulated with ATP. Spleen cells from 4-mo-old MRL+/+ (red) MRL/lpr (blue) and B6P2X7−/− (black) mice (n = 3 mice/group) were loaded with calcium-reactive fluorescence probe, Oregon Green 488 BAPTA-1. After loading, cells were stained with anti-CD90, anti-CD19 and anti-B220 mAbs. Baseline MFI of the calcium probe was recorded in the gated B220–CD90+ (○) and B220+CD90+ (▵) T cells during 50 s by flow cytometry, and was followed by the addition of 500 µM ATP (at time t0, arrow). Changes over time in MFI values of the calcium probe were monitored in the T-cell subsets by flow cytometry. MFI values were normalized by subtracting the baseline MFI.CC BY · PubMed Central
Figure 7 ATP-induced shedding of CD62L in CD4+, CD8+ and DN T lymphocytes expressing the transmembrane tyrosine phosphatase B220. Spleen cells from 3 to 5-mo-old MRL+/+, MRL/lpr, B6 and B6/lpr mice (n = 5 mice/group) were either left unstimulated (□) or stimulated with 500 µM ATP (▪) for 45 min at 37°C. Spleen cells were then stained with anti-CD90, anti-B220, anti-CD62L and anti-CD4 or anti-CD8 mAb to assess CD62L expression on B220– and B220+ CD90+ T cells (either CD4+ or CD8+) from MRL+/+, MRL/lpr, B6 and B6/lpr mice as well as on B220+ DN CD90+ T cells from MRL/lpr and B6/lpr mice. Asterisks denote statistically significant differences between ATP-stimulated and unstimulated groups: **p≤0.01; ***p≤0.001.
Figure 7 ATP-induced shedding of CD62L in CD4+, CD8+ and DN T lymphocytes expressing the transmembrane tyrosine phosphatase B220. Spleen cells from 3 to 5-mo-old MRL+/+, MRL/lpr, B6 and B6/lpr mice (n = 5 mice/group) were either left unstimulated (□) or stimulated with 500 µM ATP (▪) for 45 min at 37°C. Spleen cells were then stained with anti-CD90, anti-B220, anti-CD62L and anti-CD4 or anti-CD8 mAb to assess CD62L expression on B220– and B220+ CD90+ T cells (either CD4+ or CD8+) from MRL+/+, MRL/lpr, B6 and B6/lpr mice as well as on B220+ DN CD90+ T cells from MRL/lpr and B6/lpr mice. Asterisks denote statistically significant differences between ATP-stimulated and unstimulated groups: **p≤0.01; ***p≤0.001.CC BY · PubMed Central
Figure 8 Expression of P2X7R and CD39 in T-cell subsets. (A) The levels of CD39 expression on B220– (either CD4+ or CD8+) (□) and B220+ DN (▪) T-cell subsets as well as on CD19+ B cells (▪) from MRL/lpr mice (n = 3) were analyzed by flow cytometry. Results shown on histogram are normalized MFI (nMFI) calculated as MFI of positive cells × percentage of positive cells. Asterisks denote statistically significant differences between B220+ DN T cells or B220–CD8+ T cells and B220–CD4+ T cells: *p≤0.05; **p≤0.01. (B) P2X7R mRNA expression was analyzed in FACS-purified B220– (□) and B220+ (▪) CD19–CD90+ T-cell subsets from individual B6, MRL+/+ and MRL/lpr mice by real-time RT-PCR. Specific P2X7R cDNA was quantified by standard curves based on known amounts of PCR-amplified P2X7R cDNA. Data are expressed as amount (pg) of P2X7R RNA per cell, and histograms represent the mean ± SE of three independent experiments (n = 8 mice/group). (C) P2X7R protein levels in whole LN cells from 3 to 4-mo-old MRL+/+, MRL/lpr and B6P2X7−/− mice, and FACS-sorted B220– and B220+ CD19–CD90+ T-cell subsets from MRL/lpr mice were analyzed by western blotting using affinity-purified rabbit anti-P2X7R polyclonal antibodies (1∶1000; Alomone Laboratories). A non-specific band (*) is frequently observed with this polyclonal antibody [22]. The blot was stripped and reprobed with anti-actin mAb. (D and E) Flow cytometric analysis of P2X7R expression levels on B220– and B220+ T-cell subpopulations. Spleen cells from MRL+/+, MRL/lpr and B6P2X7R−/− mice (n = 3 mice/group) were stained with anti-CD90 mAb, anti-B220 mAb, rabbit polyclonal anti-P2X7R antiserum (1∶100) generated by genetic immunization [34] and with either anti-CD4 mAb, anti-CD8 mAb or anti-CD4 plus anti-CD8 mAbs. (D) Overlay histograms showing the expression levels of P2X7R on gated CD4 T cells or CD8 T cells from MRL+/+ mice (open histogram) and B6P2X7R−/− mice (shaded histogram). (E) Overlay histograms comparing the expression levels of P2X7R on B220– (–) and B220+ (–) T cells, either CD4+ (left) or CD8+ (middle), from MRL/lpr mice. Right, overlay histogram comparing the expression levels of P2X7R on B220+ DN T cells (–) and B220– CD4+ T cells (–) from MRL/lpr mice. The results shown are representative of at least four independent experiments.
Figure 8 Expression of P2X7R and CD39 in T-cell subsets. (A) The levels of CD39 expression on B220– (either CD4+ or CD8+) (□) and B220+ DN (▪) T-cell subsets as well as on CD19+ B cells (▪) from MRL/lpr mice (n = 3) were analyzed by flow cytometry. Results shown on histogram are normalized MFI (nMFI) calculated as MFI of positive cells × percentage of positive cells. Asterisks denote statistically significant differences between B220+ DN T cells or B220–CD8+ T cells and B220–CD4+ T cells: *p≤0.05; **p≤0.01. (B) P2X7R mRNA expression was analyzed in FACS-purified B220– (□) and B220+ (▪) CD19–CD90+ T-cell subsets from individual B6, MRL+/+ and MRL/lpr mice by real-time RT-PCR. Specific P2X7R cDNA was quantified by standard curves based on known amounts of PCR-amplified P2X7R cDNA. Data are expressed as amount (pg) of P2X7R RNA per cell, and histograms represent the mean ± SE of three independent experiments (n = 8 mice/group). (C) P2X7R protein levels in whole LN cells from 3 to 4-mo-old MRL+/+, MRL/lpr and B6P2X7−/− mice, and FACS-sorted B220– and B220+ CD19–CD90+ T-cell subsets from MRL/lpr mice were analyzed by western blotting using affinity-purified rabbit anti-P2X7R polyclonal antibodies (1∶1000; Alomone Laboratories). A non-specific band (*) is frequently observed with this polyclonal antibody [22]. The blot was stripped and reprobed with anti-actin mAb. (D and E) Flow cytometric analysis of P2X7R expression levels on B220– and B220+ T-cell subpopulations. Spleen cells from MRL+/+, MRL/lpr and B6P2X7R−/− mice (n = 3 mice/group) were stained with anti-CD90 mAb, anti-B220 mAb, rabbit polyclonal anti-P2X7R antiserum (1∶100) generated by genetic immunization [34] and with either anti-CD4 mAb, anti-CD8 mAb or anti-CD4 plus anti-CD8 mAbs. (D) Overlay histograms showing the expression levels of P2X7R on gated CD4 T cells or CD8 T cells from MRL+/+ mice (open histogram) and B6P2X7R−/− mice (shaded histogram). (E) Overlay histograms comparing the expression levels of P2X7R on B220– (–) and B220+ (–) T cells, either CD4+ (left) or CD8+ (middle), from MRL/lpr mice. Right, overlay histogram comparing the expression levels of P2X7R on B220+ DN T cells (–) and B220– CD4+ T cells (–) from MRL/lpr mice. The results shown are representative of at least four independent experiments.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Cited by

See all 19

Metadata

Authors
Le Gall, S. M., Legrand, J., Benbijja, M., Safya, H., Benihoud, K., Kanellopoulos, J. M., & Bobé, P.
Affiliations
  • Université Paris-Sud (FR)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
Bobé, Pierre
Venue
PLoS ONE
Published
2012-12-21
Volume
7
Issue
12
Pages
e52161
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1985384159
Cited by
19
References
55
Citations by year
2026: 1 · 2022: 4 · 2020: 1 · 2019: 4 · 2018: 4 · 2017: 1 · 2016: 1 · 2014: 2 · 2013: 1
FWCI
0.67
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Agence Nationale de la Recherche (ANR-07-BLAN-0089)
  • Centre National de la Recherche Scientifique
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
P2X7 receptor, MRL/lpr mice, systemic lupus erythematosus, Fas/Fas ligand pathway, ATP sensitivity, T cell apoptosis, aging, autoimmunity, T cell activation
MeSH terms
Adenosine Triphosphate, Animals, Cell Membrane, Cells, Cultured, Lymphocyte Activation, Mice, Mutant Strains, NAD, Blotting, Western, Signal Transduction, CD4 Antigens, CD8 Antigens, Mice, Inbred MRL lpr, Mice, Receptors, Purinergic P2X7, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Loss of P2X7 Receptor Plasma Membrane Expression and Function in Pathogenic B220+ Double-Negative T Lymphocytes of Autoimmune MRL/lpr Mice. https://app.cochat.ai/papers/10.1371/journal.pone.0052161
The paper
Le Gall, S. M., Legrand, J., Benbijja, M., Safya, H., Benihoud, K., Kanellopoulos, J. M., & Bobé, P. (2012). Loss of P2X7 Receptor Plasma Membrane Expression and Function in Pathogenic B220+ Double-Negative T Lymphocytes of Autoimmune MRL/lpr Mice. PLoS ONE. https://doi.org/10.1371/journal.pone.0052161

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.